Horizon 2020 Health

SC1-DTH-09-2019: Scaling up the univocal Identification of Medicinal Products

Deadline: April 24, 2019

Across the European Union, medicinal products display differences in names, variations in strength or their package size. The unavailability of a specific product may also necessitate substitution in many instances, if a patient is to be timely served in a pharmacy.

This innovation action is expected to support two goals: (i) the cross-border mobility of European patients by offering safer eDispensations across borders, (ii) the implementation of the IDMP standards in Member States drug databases (including a possible linkage to the EU SPOR - Substance, Product, Organisation and Referential master data database) allowing the identification of locally available medicinal products which are equivalent to the one identified in a foreign prescription.

Funds projects within:

The official call from Horizon 2020 Health

Request contact regarding funding from Horizon 2020 Health

Is this call right for your project? Let us contact you to discuss your possibilities within Horizon 2020 Health.

About Horizon 2020 Health

With support from Horizon 2020 Health you will be able to conduct international research projects in support of EU policies for health. Support will be given to projects aimed at: Health promotion and prevention; diagnosis improvement; innovative treatments and technologies; active and healthy aging; citizen-centered care; and improving health information etc.

More about the grant

We help you succeed

We help companies obtain public funding by converting good projects to well-prepared applications.

Our services cover the entire application process:

Identifying funding opportunities
We identifying your best funding opportunities
Planning and scoping your project
We plan and scope your project to meet demands
Writing the successful application
We write the application that increases your chance of success